Talphera CFO Raffi Asadorian sells shares worth $118
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Talphera Inc (TLPH)"Talphera Inc stock price live, this page displays NASDAQ TLPH stock exchange data. View the TLPH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Talphera Inc real time stock price chart below.
What Is the Talphera Inc Stock Price Today?
The Talphera Inc stock price today is 0.7599.
What Is the Stock Symbol for Talphera Inc?
The stock symbol for Talphera Inc is ""TLPH.""
What Stock Exchange Does Talphera Inc Trade On?
Talphera Inc is listed and trades on the NASDAQ stock exchange.
Is Talphera Inc a Good Stock to Buy?
Determining whether Talphera Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TLPH quote. (ISIN: US00444T2096)"
What Is the Talphera Inc Stock Price Today?
The Talphera Inc stock price today is 0.7599.
What Is the Stock Symbol for Talphera Inc?
The stock symbol for Talphera Inc is ""TLPH.""
What Stock Exchange Does Talphera Inc Trade On?
Talphera Inc is listed and trades on the NASDAQ stock exchange.
Is Talphera Inc a Good Stock to Buy?
Determining whether Talphera Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TLPH quote. (ISIN: US00444T2096)"
NASDAQ
Currency in USD
0.7599
+0.0064(+0.85%)
Real-time Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.7550
0.7600
52 wk Range
0.6200
1.6100
TLPH Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.75500.7600
52 wk Range
0.62001.6100
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockTLPH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Price Target
4.1667
Upside
+448.3221%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Talphera Inc Company Profile
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.
Compare TLPH to Peers and Sector
Metrics to compare | TLPH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTLPHPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.8x | −1.7x | −0.7x | |
PEG Ratio | −0.01 | 0.00 | 0.00 | |
Price/Book | 1.3x | 0.6x | 2.6x | |
Price / LTM Sales | 45.5x | 7.4x | 3.2x | |
Upside (Analyst Target) | 366.7% | 107.9% | 43.2% | |
Fair Value Upside | Unlock | 14.4% | 6.8% | Unlock |
Analysts' Recommendations
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 4.1667
(+448.32% Upside)
FAQ
What Is the Talphera (TLPH) Stock Price Today?
The Talphera stock price today is 0.7599
What Stock Exchange Does Talphera Trade On?
Talphera is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Talphera?
The stock symbol for Talphera is "TLPH."
What Is the Talphera Market Cap?
As of today, Talphera market cap is 12.77M.
What is Talphera Earnings Per Share?
The Talphera EPS is -0.655.
From a Technical Analysis Perspective, Is TLPH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.